CopyMark Law Group
4.9/5
Drawing for JARI

USPTO serial 79286644

JARI

Reviewed by CopyMark Law Group

Reg. 6253755Status 700Renewal
Filing date
Status date
Registration date
Jan 26, 2021
Examiner
CORWIN, KEVIN SCOTT
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with JARI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $325

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kevin O'Keefe

81 70th streetBrooklyn, NY 11209UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Chemical reagents for medical or veterinary purposes; medical analgesic preparations; medicines for alleviating constipation; pharmaceutical agents affecting digestive organs; Nerve tranquilizers; Laxatives; Medical ointment, namely, medicated ointments for treating dermatological conditions; Sedatives; Sleeping pills; Medical biological preparations for the treatment of cancer, high blood pressure; Medicinal chemical preparations for the treatment of cancer, high blood pressure; Medical chemical preparations, namely, medicinal preparations for the treatment of cancer, high blood pressure; Medical enzymes, namely, enzymes for medical purposes; Injectable solutions for medical purposes, namely, injectable pharmaceuticals for treatment of cancer, high blood pressure; Pharmaceuticals in tablet form for the treatment of cancer, high blood pressure; Tincture of iodine; Medical liquid in the nature of injectable solutions for medical purposes, namely, injectable pharmaceuticals for treatment of cancer, high blood pressure; Ointment for medical use, namely, medicated ointments for the treatment of cancer, high blood pressure; Gelatin capsule for medicine, namely, pharmaceuticals for the treatment of cancer, high blood pressure; medical X-ray contrast agent; Diagnostic preparations for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 26, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 7, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 7, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 7, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 23, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 30, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 30, 2021FIMPFINAL DISPOSITION PROCESSED—
Apr 26, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 26, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 10, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 10, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 21, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 5, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 24, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 24, 2020ACECAMENDMENT FROM APPLICANT ENTERED—
Aug 24, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 21, 2020ALIEASSIGNED TO LIE—
Aug 7, 2020RFNTREFUSAL PROCESSED BY IB—
Aug 4, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 4, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 20, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 20, 2020RFRRREFUSAL PROCESSED BY MPU—
Jun 14, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 13, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 5, 2020DOCKASSIGNED TO EXAMINER—
Jun 5, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 4, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance